René Beukema
General Counsel chez PROQR THERAPEUTICS N.V.
Fortune : 1 M $ au 31/03/2024
Profil
René Beukema is the founder of Impatients NV, which was founded in 2012.
He is currently a Member at Vu Medical Center and the Chief Corporate Development Officer at ProQR Therapeutics NV since 2022.
Previously, he held the position of Director at Fibriant BV from 2021 to 2024.
He also served as the Corporate Secretary & General Counsel at Crucell NV from 2010 to 2012.
Dr. Beukema was a Senior Legal Counsel at T.I.P.
Europe Ltd.
and GE Capital Europe Ltd.
from 1994 to 1999.
He was also the Corporate Secretary & General Counsel at Janssen Vaccines & Prevention BV.
Additionally, he worked as a Partner at Aescap Venture Management BV from 2011 to 2013.
Dr. Beukema started his career as a Legal Counsel at TNT Express Worldwide BV from 1991 to 1994.
He later served as the General Counsel at ProQR Therapeutics NV from 2013 to 2018.
Dr. Beukema holds a graduate degree from the University of Amsterdam and a doctorate degree from Radboud University Nijmegen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROQR THERAPEUTICS N.V.
0,57% | 31/12/2023 | 460 000 ( 0,57% ) | 1 M $ | 31/03/2024 |
Postes actifs de René Beukema
| Sociétés | Poste | Début |
|---|---|---|
| PROQR THERAPEUTICS N.V. | General Counsel | 01/01/2022 |
Vu Medical Center
 Vu Medical Center Hospital/Nursing ManagementHealth Services Vu Medical Center operates as a hospital. | Corporate Officer/Principal | - |
Anciens postes connus de René Beukema
| Sociétés | Poste | Fin |
|---|---|---|
Fibriant BV
 Fibriant BV Pharmaceuticals: OtherHealth Technology Fibriant BV is a Dutch biotechnology company that specializes in the recombinant manufacturing and characterization of specific variants of human Fibrinogen and active human Thrombin. The company is based in Leiden, the Netherlands. The company's science and technology are centered around Fibrinogen, a soluble blood protein that can be converted into an insoluble three-dimensional Fibrin network. Fibriant captures the unique features and functions of specific recombinant variants of Fibrinogen in new innovative products and in improvements of existing products based on plasma Fibrinogen. The company was founded in 2015 by Jaap Koopman, Jos Grimbergen, Miranda Weggeman, and Jaap Koopman has been the CEO since then. | Director/Board Member | 01/01/2024 |
| PROQR THERAPEUTICS N.V. | General Counsel | 31/12/2018 |
Aescap Venture Management BV
 Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Private Equity Investor | 31/12/2013 |
T.I.P. Europe Ltd.
 T.I.P. Europe Ltd. Other TransportationTransportation T.I.P. Europe Ltd. engaged in the operation of warehousing and storage facilities for land transport activities. The company was founded on March 26, 1986 and was headquartered in London, the United Kingdom. | General Counsel | 01/01/1999 |
GE Capital Europe Ltd.
 GE Capital Europe Ltd. Finance/Rental/LeasingFinance GE Capital Europe Ltd. provides consumer financing services. It offers accounts receivable, financing, consumer, equipment and healthcare finance solutions. The firm provides industry specific expertise in aviation, energy, infrastructure, healthcare, and media to capitalize on market-specific opportunities. The company is headquartered in London, the United Kingdom. | General Counsel | 01/01/1999 |
Formation de René Beukema
| University of Amsterdam | Graduate Degree |
| Radboud University Nijmegen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
T.I.P. Europe Ltd.
T.I.P. Europe Ltd. Other TransportationTransportation T.I.P. Europe Ltd. engaged in the operation of warehousing and storage facilities for land transport activities. The company was founded on March 26, 1986 and was headquartered in London, the United Kingdom. | Transportation |
GE Capital Europe Ltd.
GE Capital Europe Ltd. Finance/Rental/LeasingFinance GE Capital Europe Ltd. provides consumer financing services. It offers accounts receivable, financing, consumer, equipment and healthcare finance solutions. The firm provides industry specific expertise in aviation, energy, infrastructure, healthcare, and media to capitalize on market-specific opportunities. The company is headquartered in London, the United Kingdom. | Finance |
Janssen Vaccines & Prevention BV
 Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
Aescap Venture Management BV
Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Finance |
TNT Express Worldwide BV
 TNT Express Worldwide BV Air Freight/CouriersTransportation Part of FedEx Corp., TNT Express Worldwide BV is a Dutch company that provides logistic and international mailing services. The private company is based in Hoofddorp, Netherlands. | Transportation |
Vu Medical Center
Vu Medical Center Hospital/Nursing ManagementHealth Services Vu Medical Center operates as a hospital. | Health Services |
Impatients NV
 Impatients NV Miscellaneous Commercial ServicesCommercial Services Impatients N.V. operates an online platform for drug innovations. It provides physicians and patients that are excluded from clinical trials access to drugs in development via early access programs. The company was founded by Ronald Brus, SJaak Vink, Govert J. Schouten, Witt Jan, Erdem Yavuz, and René Beukema in 2012 and is headquartered in Amsterdam, the United Kingdom. | Commercial Services |
Fibriant BV
Fibriant BV Pharmaceuticals: OtherHealth Technology Fibriant BV is a Dutch biotechnology company that specializes in the recombinant manufacturing and characterization of specific variants of human Fibrinogen and active human Thrombin. The company is based in Leiden, the Netherlands. The company's science and technology are centered around Fibrinogen, a soluble blood protein that can be converted into an insoluble three-dimensional Fibrin network. Fibriant captures the unique features and functions of specific recombinant variants of Fibrinogen in new innovative products and in improvements of existing products based on plasma Fibrinogen. The company was founded in 2015 by Jaap Koopman, Jos Grimbergen, Miranda Weggeman, and Jaap Koopman has been the CEO since then. | Health Technology |
